
    
      The monocentric trial deals with the endocrinological changes as a result of closure of the
      left atrial appendage with a internal closure device. Specially, the changes in atrial
      natriuretic peptide, brain natriuretic peptide and their impact on exercise capacity is on
      focus of the trial. The trial is planned as a all comers trial.
    
  